Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YMAB
2976
DELISTED
Y-mAbs Therapeutics
YMAB
| $3.54M | ﹤0.01% |
81,951
+76,700
| +1,461% | +$2.9M |
|
|
GCV
2977
Gabelli Convertible and Income Securities Fund
GCV
$93.7M
| $3.54M | ﹤0.01% |
691,339
+18,399
| +3% | +$89.7K |
|
|
CLVS
2978
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.54M | ﹤0.01% |
524,506
-54,839
| -9% | -$415K |
|
2979
Dorchester Minerals
DMLP
$1.25B
| $3.54M | ﹤0.01% |
276,881
-14,624
| -5% | -$166K |
|
2980
CryoPort
CYRX
$746M
| $3.53M | ﹤0.01% |
116,807
-8,633
| -7% | -$192K |
|
2981
First Bancorp
FBP
$4.45B
| $3.53M | ﹤0.01% |
632,259
-2,332
| -0.4% | -$12.6K |
|
|
WDR
2982
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $3.52M | ﹤0.01% |
227,323
+18,402
| +9% | +$252K |
|
|
EHI
2983
Western Asset Global High Income Fund
EHI
$177M
| $3.52M | ﹤0.01% |
380,959
-21,475
| -5% | -$187K |
|
2984
iShares iBonds Dec 2028 Term Muni Bond ETF
IBMQ
$661M
| $3.52M | ﹤0.01% |
129,844
+55,543
| +75% | +$1.48M |
|
|
VRN
2985
DELISTED
Veren
VRN
| $3.52M | ﹤0.01% |
2,156,818
+355,487
| +20% | +$491K |
|
|
HMLP
2986
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $3.51M | ﹤0.01% |
361,106
-115,400
| -24% | -$1.12M |
|
2987
PJT Partners
PJT
$4.41B
| $3.51M | ﹤0.01% |
68,397
+21,151
| +45% | +$1.04M |
|
2988
First Industrial Realty Trust
FR
$8.45B
| $3.5M | ﹤0.01% |
91,075
-95,107
| -51% | -$3.48M |
|
|
TARO
2989
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $3.5M | ﹤0.01% |
52,659
+21,382
| +68% | +$1.43M |
|
2990
Axcelis
ACLS
$4.3B
| $3.5M | ﹤0.01% |
125,552
+31,794
| +34% | +$775K |
|
2991
iShares Emerging Markets Equity Factor ETF
EMGF
$1.86B
| $3.5M | ﹤0.01% |
88,768
+22,507
| +34% | +$846K |
|
2992
AerCap
AER
$24.3B
| $3.5M | ﹤0.01% |
113,510
+4,307
| +4% | +$123K |
|
2993
WisdomTree Europe Quality Dividend Growth Fund
EUDG
$70.4M
| $3.49M | ﹤0.01% |
135,539
-29,427
| -18% | -$707K |
|
2994
Tennant Co
TNC
$1.26B
| $3.49M | ﹤0.01% |
53,631
+3,023
| +6% | +$184K |
|
2995
First Trust Municipal High Income ETF
FMHI
$998M
| $3.49M | ﹤0.01% |
68,617
+31,198
| +83% | +$1.53M |
|
2996
United Microelectronic
UMC
$48.2B
| $3.49M | ﹤0.01% |
1,320,833
+703,905
| +114% | +$1.77M |
|
2997
ImmunityBio
IBRX
$7.78B
| $3.47M | ﹤0.01% |
282,480
+216,945
| +331% | +$1.22M |
|
|
HFXJ
2998
DELISTED
IQ 50 Percent Hedged FTSE Japan ETF
HFXJ
| $3.46M | ﹤0.01% |
171,901
-135,508
| -44% | -$2.63M |
|
2999
Interface
TILE
$2.04B
| $3.46M | ﹤0.01% |
424,742
-12,214
| -3% | -$104K |
|
3000
Personalis
PSNL
$1.41B
| $3.46M | ﹤0.01% |
266,532
+207,806
| +354% | +$2.31M |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,644 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.